XT
HAE icon

XTX Topco’s Haemonetics HAE Stock Holding History

XTX Topco’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.96M Buy
87,937
+76,738
+685% +$5M 0.09% 287
2025
Q4 		$898K Buy
11,199
+6,307
+129% +$424K 0.02% 1103
2025
Q3 		$238K Sell
4,892
-915
-16% -$56.6K 0.01% 1699
2025
Q2 		$433K Sell
5,807
-24,831
-81% -$1.64M 0.02% 1195
2025
Q1 		$1.95M Buy
+30,638
New +$2.08M 0.1% 267
2024
Q4 		– Sell
-8,450
Closed -$679K – 2533
2024
Q3 		$679K Buy
8,450
+3,880
+85% +$313K 0.05% 616
2024
Q2 		$378K Sell
4,570
-2,660
-37% -$234K 0.03% 819
2024
Q1 		$617K Buy
+7,230
New +$567K 0.08% 365
2023
Q4 		– Sell
-5,727
Closed -$513K – 1786
2023
Q3 		$513K Sell
5,727
-873
-13% -$77.9K 0.09% 387
2023
Q2 		$562K Buy
6,600
+3,001
+83% +$254K 0.1% 304
2023
Q1 		$298K Sell
3,599
-64
-2% -$5.18K 0.06% 654
2022
Q4 		$288K Buy
+3,663
New +$294K 0.06% 614
2021
Q3 		– Sell
-5,096
Closed -$340K – 825
2021
Q2 		$340K Buy
5,096
+2,289
+82% +$162K 0.11% 310
2021
Q1 		$312K Buy
+2,807
New +$347K 0.15% 258

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

XTX Topco's HAE Position: Q1 2026 in Review

XTX Topco increased its Haemonetics (HAE) stake by 685% in Q1 2026, buying an estimated $5M and bringing the position to 87,937 shares worth $4.96M. The position accounts for 0.09% of the portfolio, ranked #287.

XTX Topco first reported a position in HAE in Q1 2021 and has held it in 14 quarters since. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

  • XTX Topco held 87,937 shares of Haemonetics worth $4.96M as of Q1 2026.
  • XTX Topco bought 76,738 Haemonetics shares in Q1 2026, an estimated $5M.
  • Haemonetics made up 0.09% of XTX Topco's portfolio in Q1 2026, its #287 holding.
  • XTX Topco first reported a position in Haemonetics in Q1 2021 and has held it in 14 quarters since.
  • 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.